| |
| Issue |
Title |
| |
| No 2 (2020) |
Features of the phenotypic and genotypic lipid status of the indigenous ethnic group of the Arctic in the conditions of island living |
Abstract
PDF (Rus)
|
|
N. A. Vorobyeva, N. I. Belova, A. I. Vorobyeva |
| |
| No 1 (2019) |
A STRATEGY FOR MANAGING A PATIENT WITH ATRIAL FIBRILLATION TO REDUCE THE RISK OF THROMBOEMBOLIC COMPLICATIONS |
Abstract
PDF (Rus)
|
|
L. I. Kudryavtseva, E. V. Filippov |
| |
| No 1 (2019) |
DABIGATRAN AND IDARUZIZUMAB. NEW OPPORTUNITIES FOR IMPROVING PATIENT SAFETY |
Abstract
PDF (Rus)
|
|
N. A. Novikova, A. N. Volovchenko, D. A. Parfenov |
| |
| No 2 (2018) |
CONSIDERING QUESTION OF SAFETY OF DIRECT ORAL ANTICOAGULANTS: THE RESULTS OF THE COMPARISON OF APIXABAN AND WARFARIN |
Abstract
PDF (Rus)
|
|
Igor S. Yavelov |
| |
| No 2 (2018) |
ATRIAL FIBRILLATION COMBINED WITH DIABETES MELLITUS. POSSIBILITIES OF USING RIVAROXABAN |
Abstract
PDF (Rus)
|
|
Alexey D. Ehrlich |
| |
| No 1 (2018) |
SIGNIFICANCE OF THE COMPASS STUDY RESULTS FOR CLINICAL PRACTICE. EXPERT COUNCIL OPINION OF NOVEMBER 22, 2017 |
Abstract
PDF (Rus)
|
|
Article Editorial |
| |
| No 2 (2017) |
HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? |
Abstract
PDF (Rus)
|
|
E. P. PANCHENKO |
| |
| No 2 (2017) |
NICHE OF PRASUGREL AMONG OTHER PLATELET P2Y12-RECEPTOR INHIBITORS |
Abstract
PDF (Rus)
|
|
P. S. LAGUTA, E. P. PANCHENKO |
| |
| No 2 (2016) |
ВЛИЯНИЕ КОМБИНИРОВАННОЙ ТЕРАПИИ НА ЦЕНТРАЛЬНОЕ АРТЕРИАЛЬНОЕ ДАВЛЕНИЕ И АРТЕРИАЛЬНУЮ РИГИДНОСТЬ |
Abstract
PDF (Rus)
|
|
, , |
| |
| No 1 (2017) |
ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF STROKE |
Abstract
PDF (Rus)
|
|
P. S. Laguta |
| |
| No 1 (2017) |
APIXABAN IN THE TREATMENT OF ATRIAL FIBRILLATION: RANDOMIZED TRIALS AND EVERYDAY CLINICAL PRACTICE |
Abstract
PDF (Rus)
|
|
O. O. Shakhmatova, E. P. Panchenko |
| |
| No 1 (2017) |
IS THE SYNTAX SCORE SUFFICIENT TO ASSESS THE RISK FOR PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTIONS? |
Abstract
PDF (Rus)
|
|
E. S. Novikova, A. L. Komarov, E. V. Gus’kova, O. O. Shakhmatova, A. D. Deyev, A. B. Dobrovolsky, A. N. Samko, E. P. Panchenko |
| |
| No 1 (2017) |
LIPID CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION - AN EFFECTIVE TOOL FOR MANAGING CARDIOVASCULAR RISKS |
Abstract
PDF (Rus)
|
|
O. L. Barbarash, V. V. Kashtalap |
| |
| No 2 (2016) |
СОВРЕМЕННЫЕ ПОДХОДЫ К СТРАТИФИКАЦИИ РИСКА БОЛЬНЫХ, ПОДВЕРГАЕМЫХ ПЛАНОВЫМ ЧРЕСКОЖНЫМ КОРОНАРНЫМ ВМЕШАТЕЛЬСТВАМ |
Abstract
PDF (Rus)
|
|
, |
| |
| No 2 (2016) |
СНИЖЕНИЕ РИСКА СЕРДЕЧНО-СОСУДИСТОЙ СМЕРТНОСТИ И ИНСУЛЬТА У ПАЦИЕНТОВ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ |
Abstract
PDF (Rus)
|
|
, |
| |
| No 2 (2016) |
ПРОФИЛАКТИКА ПОВТОРНОГО НЕКАРДИОЭМБОЛИЧЕСКОГО ИШЕМИЧЕСКОГО ИНСУЛЬТА НА ОСНОВЕ АНТИТРОМБОЦИТАРНЫХ СРЕДСТВ |
Abstract
PDF (Rus)
|
|
, |
| |
| No 2 (2016) |
МЕСТО И ЗНАЧЕНИЕ НАБЛЮДАТЕЛЬНЫХ ИССЛЕДОВАНИЙ НОАК У ПАЦИЕНТОВ С НЕКЛАПАННОЙ ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ С ПОЗИЦИИ МЕДИЦИНЫ, ОСНОВАННОЙ НА ДОКАЗАТЕЛЬСТВАХ |
Abstract
PDF (Rus)
|
|
, , , , , , , , , , , , , , , , , , |
| |
| 1 - 17 of 17 Items |
|
